Literature DB >> 8242765

The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion.

Y Nojima1, T Hirose, K Tachibana, T Tanaka, L Shi, J Doshen, G J Freeman, S F Schlossman, C Morimoto.   

Abstract

In this report, we describe a 43- to 50-kDa protein, which may function as a costimulatory molecule for full activation of human T cells. This Ag, defined by a mouse monoclonal antibody (mAb) anti-4F9, is primarily distributed on "helper/inducer" or "memory" CD4+CD45RO+ subset. Like mAbs against many other accessory/costimulatory molecules, coimmobilization of anti-4F9 with anti-CD3 resulted in synergistic T cell proliferation. In addition, immobilized anti-4F9 on plastic plates induced T cell spreading characterized by the development of prominent dendritic processes. A cDNA encoding the 4F9 Ag was isolated from a cDNA library constructed from PHA/PMA-activated T cells using a COS cell expression system. The sequence of the cDNA and a homology search revealed that the 4F9 Ag was identical to R2, a molecule recently cloned by subtractive hybridization. The 4F9/R2 Ag belongs to a newly identified supergene family (tetra spans transmembrane protein family) characterized by four putative transmembrane domains which are highly conserved between the members of this family. Based upon the phenotypical and functional studies described here, we propose that the 4F9 Ag is an integral membrane protein which can transmit signals involved in T cell proliferation and adhesion. The preferential distribution of this molecule on the CD4+CD45RO+ subset of T cells may contribute to the distinct activation profile and functional repertoire of these cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242765     DOI: 10.1006/cimm.1993.1285

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins).

Authors:  F Berditchevski; M M Zutter; M E Hemler
Journal:  Mol Biol Cell       Date:  1996-02       Impact factor: 4.138

2.  Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.

Authors:  T Ueda; T Ichikawa; J Tamaru; A Mikata; K Akakura; S Akimoto; T Imai; O Yoshie; T Shiraishi; R Yatani; H Ito; J Shimazaki
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 3.  Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.

Authors:  Yien Che Tsai; Allan M Weissman
Journal:  FEBS Lett       Date:  2011-08-27       Impact factor: 4.124

4.  A role for CD9 molecules in T cell activation.

Authors:  X G Tai; Y Yashiro; R Abe; K Toyooka; C R Wood; J Morris; A Long; S Ono; M Kobayashi; T Hamaoka; S Neben; H Fujiwara
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

5.  The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation.

Authors:  H Kobayashi; O Hosono; S Iwata; H Kawasaki; M Kuwana; H Tanaka; N H Dang; C Morimoto
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 6.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

7.  Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.

Authors:  Rafijul Bari; Yanhui H Zhang; Feng Zhang; Nick X Wang; Christopher S Stipp; Jie J Zheng; Xin A Zhang
Journal:  Am J Pathol       Date:  2008-12-30       Impact factor: 4.307

8.  Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.

Authors:  Dhruv Kumar; Dwijendra Gupta; Sharmila Shankar; Rakesh K Srivastava
Journal:  Oncotarget       Date:  2015-02-20

9.  Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells.

Authors:  A Takaoka; Y Hinoda; S Sato; F Itoh; M Adachi; M Hareyama; K Imai
Journal:  Jpn J Cancer Res       Date:  1998-04

10.  Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.

Authors:  Wei M Liu; Feng Zhang; Simon Moshiach; Bin Zhou; Chao Huang; Kamalakkannan Srinivasan; Seema Khurana; Yi Zheng; Jill M Lahti; Xin A Zhang
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.